deltatrials
Completed PHASE2/PHASE3 NCT01546792

Lifestyle Intervention in Obstructive Sleep Apnoea

Effects of a Lifestyle Intervention on Quality of Life, Weight Loss and Cardiovascular Risk in Patients With Obstructive Sleep Apnoea Established on Continuous Positive Airway Pressure

Sponsor: Sheffield Hallam University

Conditions Obesity Obstructive Sleep Apnoea
Interventions Combined lifestyle intervention
Updated 5 times since 2017 Last updated: Mar 1, 2012 Started: Jan 31, 2010 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

A PHASE2/PHASE3 clinical study on Obesity and Obstructive Sleep Apnoea, this trial is completed. The trial is conducted by Sheffield Hallam University and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sheffield Hallam University
  • Sheffield Teaching Hospitals NHS Foundation Trust
Data source: Sheffield Teaching Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Sheffield, United Kingdom